Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02318953
Other study ID # 2013 0094 B
Secondary ID
Status Completed
Phase N/A
First received December 12, 2014
Last updated October 6, 2015
Start date January 2015
Est. completion date August 2015

Study information

Verified date October 2015
Source Women's College Hospital
Contact n/a
Is FDA regulated No
Health authority Canada: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This study evaluate if in an ambulatory breast reconstruction patient population at Women's College Hospital (WCH), can we avert in-person follow-up care through the use of mobile app home monitoring compared to conventional, in-person follow-up care in the first 30-days following surgery.


Description:

Women's College Hospital offers specialized surgical procedures, including breast reconstruction. Patients often travel great distances to undergo surgery. The average ambulatory breast reconstruction patient travels 76 km from home to hospital, with the furthest patient coming from 540 km away.

Most patients receiving ambulatory breast reconstruction have a low rate of postoperative events necessitating clinic visits. However, regular follow-up is still considered important in the early post-operative phase. Increasingly, telemedicine is used to overcome the distance patients must travel to receive specialized care. Telemedicine data suggests that mobile monitoring and follow-up care is valued by patients and can reduce costs to society (1-3).

Currently, Women's College Hospital is using a mobile application (QoC Health Inc., Toronto) to complement in-person postoperative follow-up care for breast reconstruction patients.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date August 2015
Est. primary completion date August 2015
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients undergoing breast reconstruction at Women's College Hospital. They must be able to use a mobile device and communicate in English.

Exclusion Criteria:

- They must be non-smokers because smokers carry increased rates of complication and both surgeons have a policy to solely operate on non-smokers (minimum smoke-free period of one month leading to surgery). Pain ratings captured in the VAS and QoR9 are important for judging quality of postoperative recovery. Pre-existing pain or an inability to take narcotics would compromise the reliability of these measures. Therefore, patients must not suffer from chronic pain. They must not be taking narcotic (morphine-like) medication for pain on a regular basis. They must not have an allergy to local anesthetics or morphine-like medications.

Accommodation of special populations: Patients with hearing or speaking impairments will be accommodated with the help of translator. The person who regularly attends visits with her will facilitate this, or if no such person is available, we will use a hospital translator. All patients will receive an explanation of the study and the consent form in writing. All material will be understandable by patients with a grade 6 reading level. If our patients have lower than a grade 6 reading level, we will ask them if there is a family member at home who could assist them with the use of the mobile device.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms

  • Use of Mobile App Home Monitoring After Ambulatory Surgery

Intervention

Device:
Mobile app follow-up care
The mobile app follow-up care is an application that can be loaded on to a smartphone. It allows the patient to submit photos of their surgical site, VAS pain scores, and QoR9 scores. The information collected is transmitted to members of the surgical team (i.e. the primary surgeon) and used to monitor recovery over the first 30-days following surgery.
Other:
Conventional, in-person follow-up care
This includes a typical in-person visit with the operating surgeon at one- and four-weeks after surgery.

Locations

Country Name City State
Canada Women's College Hospital Toronto Ontario

Sponsors (2)

Lead Sponsor Collaborator
Women's College Hospital Canadian Institutes of Health Research (CIHR)

Country where clinical trial is conducted

Canada, 

References & Publications (6)

Bailey J, Roland M, Roberts C. Is follow up by specialists routinely needed after elective surgery? A controlled trial. J Epidemiol Community Health. 1999 Feb;53(2):118-24. — View Citation

Hwa K, Wren SM. Telehealth follow-up in lieu of postoperative clinic visit for ambulatory surgery: results of a pilot program. JAMA Surg. 2013 Sep;148(9):823-7. doi: 10.1001/jamasurg.2013.2672. — View Citation

Jones DT, Yoon MJ, Licameli G. Effectiveness of postoperative follow-up telephone interviews for patients who underwent adenotonsillectomy: a retrospective study. Arch Otolaryngol Head Neck Surg. 2007 Nov;133(11):1091-5. — View Citation

Kazaure HS, Roman SA, Sosa JA. Association of postdischarge complications with reoperation and mortality in general surgery. Arch Surg. 2012 Nov;147(11):1000-7. doi: 10.1001/2013.jamasurg.114. — View Citation

Myles PS, Hunt JO, Nightingale CE, Fletcher H, Beh T, Tanil D, Nagy A, Rubinstein A, Ponsford JL. Development and psychometric testing of a quality of recovery score after general anesthesia and surgery in adults. Anesth Analg. 1999 Jan;88(1):83-90. — View Citation

Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996 Oct 23-30;276(16):1339-41. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The total number of physician visits related to the surgery The total number of physician visits will include visits to the specialist, family physician, and emergency department related to surgery. This data will be captured by patient survey at two- and four-weeks after surgery. 30 days No
Secondary The total number of health care telephone calls and emails related to the surgery. The total number of health care telephone calls and emails will include specialist, family physician, and emergency services. This data will be captured by patient survey at two- and four-weeks after surgery. 30 days No
Secondary Number of complications We will record and report all complications occurring within the 30-day period. This was chosen based on literature surrounding postoperative complications in the first 30-days (4). This will be captured by patient survey at two- and four-weeks after surgery. 30 days No
Secondary Societal and healthcare system costs A societal perspective will be adopted wherein all cost are assessed irrespective of the payer. This perspective was chosen based on the US Panel on Cost-Effectiveness in Health and Medicine recommendations. This recommendation is meant to improve comparability and consistency across studies (5). Furthermore, while a broad societal perspective will be adopted, results will also be presented using a narrower health system perspective that may be of key interest to health administrators and policy decision makers. This alternative perspective focuses on costs borne within the health system and excludes external costs as well as costs borne by patients and their caregivers. 30 days No
Secondary Patient satisfaction Currently, there are no validated questionnaires that capture patient satisfaction with postoperative care. We have created a post-pilot survey that captures patient satisfaction with the care and information received. All answers are recorded using a 5-point likert scale. This will be captured at four-weeks after surgery. We will also use the QoR-9 scores and pain VAS scores recorded at one- and four-weeks postoperative. Psychometric properties of the QoR9 include convergent validity and discriminant construct validity. There is also good interrater agreement and internal consistency. The test-retest reliability was 0.61 (p<0.0001). The preferred cut-off is 0.7; however, the QoR9 was still favoured over the quality of recovery-40 (QoR40) questionnaire due to its ease of use (< 2 minutes required to complete the survey) (6). This will be captured in both groups at one- and four-weeks after surgery. 30 days No